Word

INSIGHTA

Status

Pending

Status Code

661

Status Date

Thursday, May 16, 2024

Serial Number

97886869

Mark Type

4

Filing Date

Thursday, April 13, 2023

Trademark Owner History

Insighta Limited

Classifications

9 Apparatus for recording, transmission or reproduction of sound and images; data processing equipment and computers; computer systems comprised of hardware and downloadable computer hardware for the medical diagnostic instruments for data analysis of genetic and disease testing; downloadable software for data analysis of genetic and disease testing and medical apparatus and instruments for detecting and treating cancer; automated laboratory apparatus and computer systems, namely, nucleic acid extraction instruments and sequencers for use in analysis of biomolecules; nucleic acid sequencers for sceientific purposes; downloadable computer software for data collection, management, and analysis of genetic information for use in the field of diagnostic and clinical research and for clinical diagnostic purposes and scientific research; downloadable computer software for use in database management; computer readable medical reports recorded on magnetic and optical media; biotechnology related software; namely, downloadable software for medical diagnostic software for data analysis of genetic and disease testing; DNA testing apparatus which carry or hold DNA samples, namely, nucleic acid extraction instruments and sequencers

5 Pharmaceutical, medical and veterinary preparations for use in medical and diagnostic purposes; medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents, enzymes, and nucleotides for use in genetic testing for medical and medical diagnostic purposes; diagnostic tests and test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for determination of genetic information for medical purposes; pharmaceutical products for use in medical and diagnostic purposes; diagnostic medical reagents for medical use; medical diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads; diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for use in the fields of scientific, pharmaceutical and medical research, namely, for use in genetic and disease testing; diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for scientific use namely for use in genetic and disease testing; chemical test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for scientific, clinical or medical laboratory use, namely, for use in genetic and disease testing

1 Chemicals used in industry and science; assays and reagents for scientific and research use; diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical reagents and kits containing same, each for scientific purposes; reagents, enzymes, and nucleotides for medical research use

44 Medical services; veterinary services; hygienic and beauty care services for human beings and animals; medical diagnostic testing and reporting services; medical services, namely, analysis of biomolecules relating to diagnosing or screening cancer, diagnostic, forensic, namely, analysis of biomolecules relating to studying genetics and DNA and genetic medical testing services for others

10 Surgical and medical apparatus and instruments for medical use; apparatus for use in medical analysis for analyzing body fluids and nucleic acid; cholesterol testing apparatus for medical diagnostic purposes; diagnostic apparatus for medical purposes for genetic and disease testing; electrophoresis apparatus for medical purposes; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatus for medical rehabilitative purposes; physical exercise footwear for medical rehabilitation purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting and treating cancer; imaging devices, namely, endoscopic equipment for medical purposes and magnetic resonance imaging apparatus for medical purposes; laboratory equipment, namely, incubators for medical purposes and medical diagnostic instruments for the analysis of body fluids; scientific measuring apparatus and instruments, namely, medical diagnostic instruments for data anlysis of genetic and disease testing; medical apparatus and instruments for detecting and treating cancer; scientific equipment and instruments, namely, medical diagnostic instrumens for data analysis of genetic and disease testing; medical apparatus and instruments for detecting and treating cancer

42 Scientific and technological services and research and design relating thereto, namely, design and development of testing for use in analysis of biomolecules relating to diagnosing or screening cancer and studying genetics and DNA; scientific research and development; medical research; design and development of computer hardware and software; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and research related thereto; computer services, namely, computer diagnostic services and computer graphics services; software as a services (SAAS) service featuring software for providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; scientific consulting services in the field of genetic science and scientific research; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and computer databases maintained on software used in the field of analysis of biomolecules; scientific consultancy, information and advisory services in the field of analysis of biomolecules; product development in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, namely, analysis of biomolecules relating to diagnosing or screening cancer and studying genetics and DNA and chemical screening and diagnostic services for others; product research and development for others, and design for others, all in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research services; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; chemical screening analysis, namely, drug screening for scientic purposes; research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and chemical screening and diagnostic services for others; research, development and design of pharmaceutical and health care products; scientific research services, namely, gene sequencing services utilizing testing probes containing biochemical marker labels and analytic software; database development services; analyzing of nucleic acids and proteins, among which the analyzing of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality and specification of same; scientific and medical research; clinical diagnostic services for research purposes in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings and animals

The wording INSIGHTA has no meaning in a foreign language.

Trademark Events

Apr 17, 2023

New Application Entered

May 8, 2023

New Application Office Supplied Data Entered

Jan 9, 2024

Assigned To Examiner

Jan 16, 2024

Non-Final Action Written

Jan 16, 2024

Non-Final Action E-Mailed

Jan 16, 2024

Notification Of Non-Final Action E-Mailed

Mar 12, 2024

Correspondence Received In Law Office

Mar 12, 2024

Teas/Email Correspondence Entered

Mar 12, 2024

Teas Response To Office Action Received

Apr 8, 2024

Non-Final Action E-Mailed

Apr 8, 2024

Non-Final Action Written

Apr 8, 2024

Notification Of Non-Final Action E-Mailed

May 16, 2024

Correspondence Received In Law Office

May 16, 2024

Teas/Email Correspondence Entered

May 16, 2024

Teas Response To Office Action Received